ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1613
    Dactylitis in Early Spondyloarthritis. Baseline Data from a Prospective French National Cohort
  • Abstract Number: 589
    DAS28-CRP Versus DAS28-ESR and Thresholds for Disease Activity Category: Blinded Data from the Ongoing Phase IIb Trial with the EP4 Receptor Antagonist CR6086 in DMARD-Naïve Patients with Early Rheumatoid Arthritis
  • Abstract Number: 99
    DC-Hil+ Myeloid-Derived Suppressor Cells Are Elevated in the Peripheral Blood and Lesional Skin of Cutaneous Lupus Patients
  • Abstract Number: 2948
    Deconstructing the in Situ Myeloid Cell Microenvironment in Human Lupus Nephritis Tissue
  • Abstract Number: 78
    Decreased B Cell Ataxia-Telangiectasia Mutated Expression and Receptor Diversity Identify a Subset of Rheumatoid Arthritis Patients with Increased Joint Erosion Prevalence
  • Abstract Number: 1392
    Decreased Injection Site Pain Associated with New Etanercept Formulation in Patients with Rheumatoid Arthritis or Psoriatic Arthritis
  • Abstract Number: 1447
    Decreased Lymphatic Drainage in the Hands of Flaring RA Patients As Measured By Indocyanine Green Clearance Via Real Time Near Infrared Imaging
  • Abstract Number: 176
    Deductive Anatomy By Self-Examination. a Novel Method to Reinforce Traditional Teaching of Musculoskeletal Anatomy
  • Abstract Number: 175
    Deductive Anatomy By Self-Examination. Preliminary Evaluation of a Novel Method to Reinforce Knowledge of Musculoskeletal Anatomy at the 2018 Panlar Meeting
  • Abstract Number: 149
    Deep Immune-Profiling of CD4+ T Cells in Behçet’s Disease
  • Abstract Number: 2426
    Defining a Standardized Core Data Set for Pregnancy Registers in Rheumatic Diseases – an European Approach
  • Abstract Number: 2182
    Defining Alendronate Drug Holidays and Re-Initiation in US Medicare Data
  • Abstract Number: 1845
    Defining and Examining Retention in Care in an Urban Lupus Cohort
  • Abstract Number: 2258
    Defining Characteristics of Patients with Overlap between Sarcoidosis and Connective Tissue Diseases
  • Abstract Number: 965
    Defining Cutoffs Corresponding to Low Levels of Disease Activity in Psoriatic Arthritis, Using the Patient-Reported Psoriatic Arthritis Impact of Disease Questionnaire (PsAID12). an Analysis of 436 Patients
  • Abstract Number: 1918
    Defining Pain That Does Not Interfere with Activities Among Rheumatoid Arthritis (RA) Patients
  • Abstract Number: 906
    Defining the Gut Microbiome in Patients with ANCA-Associated Vasculitis
  • Abstract Number: 674
    Defining the Therapeutic Target in Psoriatic Arthritis: MDA Versus Dapsa
  • Abstract Number: 2703
    Delay in Initiation of Therapy Predicts Worse Outcomes in Scleroderma Renal Crisis
  • Abstract Number: 911
    Demographic and Clinical Characteristics Reflect Differences in Osteoarthritis Phenotypes of the Lumbar Spine: The Johnston County Osteoarthritis Project
  • Abstract Number: 796
    Demographic and Clinical Features of Systemic Sclerosis Patients with Anti-U1RNP Antibodies: A European Scleroderma Trials and Research (EUSTAR) Analysis
  • Abstract Number: 31
    Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Inflammation and Joint Damage in the TNF-Tg Mouse Model
  • Abstract Number: 90
    Deoxyribonuclease 1-like-3 Digests Self-DNA from Dead Cells and Prevents Autoimmunity
  • Abstract Number: 1598
    Depression and Anxiety Reduce Probability of Achieving a State of Minimal Disease Activity in Patients with Psoriatic Arthritis
  • Abstract Number: 1389
    Depression and the Patient Reported Outcomes Measurement Information System in Systemic Lupus Erythematosus
  • Abstract Number: 1660
    Depression Has a Greater Impact on Psoriatic Arthritis Than Rheumatoid Arthritis
  • Abstract Number: 1510
    Depression Is a Major Driver of Functional Capacity in Patients with Rheumatoid Arthritis Regardless of Disease Activity
  • Abstract Number: 292
    Derivation of a National Rheumatoid Arthritis Cohort in the Veterans Health Administration and Validation with the Veterans Affairs Rheumatoid Arthritis Registry
  • Abstract Number: 938
    Dermal Lymphatic Dysfunction and Photosensitivity in the MRL/Lpr Lupus Model
  • Abstract Number: 876
    Dermatomyositis Skin Shares Type I Interferon Overlap with Cutaneous Lupus but Displays Many Unique Expression Changes That May Serve As Biomarkers for Skin Disease
  • Abstract Number: 2590
    Descriptive Comparisons of the Impact of Apremilast and Methotrexate Monotherapy in Patients with Oligoarticular Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
  • Abstract Number: 1738
    Detect Outperforms Echocardiography Based Screening Guidelines for Early Detection of Systemic Sclerosis Associated Pulmonary Arterial Hypertension
  • Abstract Number: 2207
    Detecting Hand Joint Ankylosis in Radiographic Images Using Deep Learning: A Step in Development of Automatic Radiographic Scoring System for Bone Destruction
  • Abstract Number: 1370
    Detection of an Autoantibody Profile to Characterize Patients with Early (Pre-symptomatic) Knee Osteoarthritis: Data from the Osteoarthritis Initiative
  • Abstract Number: 1967
    Detection of Association of Long Noncoding RNA ATP6V0E2-AS1 Single Nucleotide Polymorphism with Susceptibility to Myeloperoxidase-ANCA Associated Vasculitis Based on Transcriptome Analysis
  • Abstract Number: 2216
    Detection of Left Ventricular Regional Function in Primary Sjögren’s Syndrome Patients without Cardiac Symptons, As Assessed By Feature Tracking Cardiac Magnetic Resonance Imaging
  • Abstract Number: 1052
    Detection of Precursors of RANK- Osteoclast-like Cells (Olcs) in Peripheral Blood and Olcs in Bone Tissue from Rheumatoid Arthritis Patients
  • Abstract Number: 2964
    Detection of Uric Acid Crystals in the Vasculature of Patients with Gout Using Dual-Energy Computed Tomography
  • Abstract Number: 754
    Determinants of Major Neurocognitive Disorder (Vascular Dementia) in SLE: The Importance of Treatment Adherence of SLE Disease Activity and Cardiovascular Risk Factors
  • Abstract Number: 2496
    Determination of the Minimally Important Difference for Interpreting the RA Multi-Biomarker Disease Activity Test Score: Impact of Diurnal and Daily Biomarker Variation on Scores Adjusted for Age, Sex and Adiposity
  • Abstract Number: 2410
    Determining the Need for Fatigue Management Resources for Young Adults with Rheumatic Disease
  • Abstract Number: 1263
    Develop a Master Algorithm for Drug Withdraw Strategy in Reduction of Adverse Events – a Machine Learning Model from the Smart System of Disease Management (SSDM)
  • Abstract Number: 2194
    Develop a New Platform for Post-Marketing Vigilance Though Smart System of Disease Management (SSDM) Mobiles Tools: A Real World Cohort Study of RA Patients from China
  • Abstract Number: 1037
    Develop an in Vitro Model to Test the Different Behavior of mtDNA in OA and Healthy Patients, Based on Mitochondrial Activity and Metabolic Response
  • Abstract Number: 2298
    Developing a Classification Criteria for Cutaneous Dermatomyositis Utilizing the Delphi Technique
  • Abstract Number: 1261
    Development a Core Domain Set to Assess Shared Decision Making Interventions in Rheumatology: An OMERACT White Paper to Facilitate Endorsement
  • Abstract Number: 2181
    Development and Feasibility of a Web-Based Data Capture System to Collect Uniform Comprehensive Post-Total Knee Replacement Physical Therapy Intervention Data for Both Clinical and Research Purposes
  • Abstract Number: 2671
    Development and First-in-Human Characterization of an ICOSL and BAFF Bispecific Inhibitor AMG 570 for SLE Treatment
  • Abstract Number: 331
    Development and Implementation of a Patient-Reported Outcomes Measurement Information System (MyRheum)
  • Abstract Number: 1394
    Development and Pilot of a Patient Satisfaction Scale in Rheumatology
  • Abstract Number: 314
    Development and Preliminary Validation of an Omeract Magnetic Resonance Imaging (MRI) Scoring System for Ankle Enthesitis in Spondyloarthritis
  • Abstract Number: 1860
    Development and Validation of a Microrna Panel to Differentiate between Patients with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Control Subjects
  • Abstract Number: 2474
    Development of a Crosswalk for FACIT-10 (Psychometric Work)
  • Abstract Number: 320
    Development of a Magnetic Resonance Imaging Atlas for the Classification of Osteoarthritis of the First Metatarsophalangeal Joint
  • Abstract Number: 2816
    Development of a Microrna Panel for Predicting Coronary Atherosclerosis in Rheumatoid Arthritis
  • Abstract Number: 1042
    Development of a Neo-Epitope Specific Assay for Serological Assessment of Type X Collagen Degradation and Its Potential Diagnostic Value for Knee Osteoarthritis
  • Abstract Number: 2141
    Development of a Pediatric Glucocorticoid Toxicity Index
  • Abstract Number: 1455
    Development of a Predictive Model of Radiological Damage in Patients with Rheumatoid Arthritis Based on Artificial Intelligence
  • Abstract Number: 2910
    Development of a Rheumatoid Arthritis Global Outcome Measure to Enable Comparisons of Patient Experiences across Treatment Arms in Randomized Clinical Trials
  • Abstract Number: 2959
    Development of a Set of Potentially Preventable Adverse Conditions Specific to Lupus: A Delphi Consensus Study
  • Abstract Number: 2514
    Development of a Subcutaneous Formulation of CT-P13 (Infliximab): Maintenance Subcutaneous Administration May Elicit Lower Immunogenicity Compared to Intravenous Treatment
  • Abstract Number: 999
    Development of an Affimab Engineered to Simultaneously Target IL-6 and Tnfα for Therapeutic Use in Rheumatoid Arthritis
  • Abstract Number: 281
    Development of an African American Lupus Community-Based Patient and Provider Education Program: Lupus Conversations
  • Abstract Number: 209
    Development of an Algorithm for the Classification of Cardiovascular Comorbidity in Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative
  • Abstract Number: 1706
    Development of an Online Lupus Self-Management Program Based on the Transtheoretical Model of Change
  • Abstract Number: 184
    Development of Focused Musculoskeletal Ultrasound Training for Primary Care Providers to Facilitate the Diagnosis of Gout: Initial Steps in an Educational Needs Assessment
  • Abstract Number: 1559
    Development of Lymphoma in Patients with Sjogren’s Syndrome
  • Abstract Number: 163
    Development of New International Classification Criteria for Antiphospholipid Syndrome: Phase II Item Reduction Survey
  • Abstract Number: 816
    Development of Thoracic Aortic Aneurysms in Patients with Polymyalgia Rheumatica: Underdiagnosed Giant Cell Arteritis?
  • Abstract Number: 242
    DHEA Deficiency in Fibromyalgia
  • Abstract Number: 1368
    Diabetes Mellitus Is Not a Risk Factor for Knee Osteoarthritis, a Systematic Review and Meta-Analysis
  • Abstract Number: 1229
    Diagnosing Prosthetic Joint Infections in Patients with Inflammatory Arthritis
  • Abstract Number: 760
    Diagnosing SLE Arthritis with Dynamic Diffuse Optical Spectroscopy
  • Abstract Number: 1835
    Diagnosis of Fibromyalgia: Disagreement between Fibromyalgia Criteria and Clinician-Based Fibromyalgia Diagnosis in a University Clinic
  • Abstract Number: 2155
    Diagnosis of Systemic Sclerosis in the United Kingdom: An Observational Study Using the Clinical Practice Research Datalink
  • Abstract Number: 2962
    Diagnostic Accuracy of Gout in Electronic Health Records and the Role of Rheumatology Electronic Consults
  • Abstract Number: 1735
    Diagnostic Accuracy of MR Angiography in a Cohort with Systemic Sclerosis Compared to Other Rheumatic Diseases with Acral Hypoperfusion
  • Abstract Number: 2909
    Diagnostic and Prognostic Value of Ultrasound Compared with Plain Radiography in Knee Osteoarthritis
  • Abstract Number: 2773
    Diagnostic and Therapeutic Management of a Suspected Case of GCA: An Opinion Survey
  • Abstract Number: 638
    Diagnostic Delay and Associated Factors in Axial Spondyloarthritis across Europe. Results from the European Map of Axial Spondyloarthritis Survey
  • Abstract Number: 266
    Diagnostic Delays and Disparities in Access to Care in Systemic Lupus Erythematosus
  • Abstract Number: 1569
    Diagnostic Performance of Labial Salivary Gland Biosy, Serological and Clinical Data in Sjogrens Syndrome. in Argentinian Multicenter
  • Abstract Number: 655
    Diagnostic Performance of MRI Lesions in the Sacroiliac Joints According to Updated Assessments in Spondyloarthritis International Society Lesion Definitions: A Central Reader Assessment of MRI Scans from the Assessments in Spondyloarthritis Classification Cohort
  • Abstract Number: 1441
    Diagnostic Performances of Antibodies Against Carbamylated Proteins in US Based Populations with Rheumatoid Arthritis and Other Autoimmune Rheumatic Diseases
  • Abstract Number: 1310
    Diagnostic Utility of Myositis Antibodies in Patients with Interstitial Lung Disease and Suspected Underlying Connective Tissue Disease
  • Abstract Number: 312
    Diagnostic Value of MRI in Non-Radiographic Axial Spondyloarthritis
  • Abstract Number: 805
    Diastolic Dysfunction in Scleroderma: An Investigation into Associated Risk Factors and Impact on Survival
  • Abstract Number: 2321
    Dickkopf-1 Serum Levels in Patients with Systemic Sclerosis and Correlation with Trabecular Bone Score
  • Abstract Number: 1132
    Diet Modification for Gout Patients: Effects on Gout Attacks and Risk Factors for Metabolic Syndrome
  • Abstract Number: 64
    Dietary Magnesium Modulates the Intestinal Microbiome and T Cell Subsets
  • Abstract Number: 1695
    Differences between Early and Adult-Onset Systemic Lupus Erythematosus in Cohort of Argentinian Patients
  • Abstract Number: 386
    Differences in Body Composition in Myositis Patients and Healthy Controls Are Associated with Disease Activity and Duration, Inflammatory Status, Skeletal Muscle Involvement and Physical Activity
  • Abstract Number: 2961
    Differences in Healthcare Transition Views, Practices, and Barriers Among North American Pediatric Rheumatology Providers from 2010 to 2018
  • Abstract Number: 2180
    Differences in Longitudinal Disease Activity Measures between Research Cohort and Non-Cohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data
  • Abstract Number: 1407
    Differences in the Measurement Properties of the Patient-Reported Outcomes Measurement Information System Physical Function Short-Form 10a Among Racial/Ethnic Minorities with Rheumatoid Arthritis
  • Abstract Number: 1035
    Different Cartilage-Bone Unit in Patients with Primary Osteoarthritis and Secondary Osteoarthritis Caused By Rheumatoid Arthritis
  • Abstract Number: 2023
    Different Patterns of Interferon-Response-Gene Expression May Elucidate Different Pathomechanisms That Drive IFN-Response-Gene Activation in Patients with Presumed IFN-Mediated Autoinflammatory Diseases
  • Abstract Number: 2673
    Different Risk Profiles for Development of Steroid-Related and Steroid-Unrelated Damage in Early Diagnosed SLE: Results from the Italian Multicenter Early Lupus Project Inception Cohort
  • Abstract Number: 709
    Differential Characteristics of Lupus Psychosis and Steroid Psychosis
  • Abstract Number: 1442
    Differential Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry and a Universal Metabolome Standard Reveals a Metabolome Profile with Consistent Accuracy for Rheumatoid Arthritis
  • Abstract Number: 844
    Differential Roles of Tnfα-TNFR1 and Tnfα-TNFR2 in the Differentiation and Function of Induced CD4+Foxp3+ Treg Cells in Autoimmune Diseases
  • Abstract Number: 1059
    Differentially-Utilized Transcription Factors and Enhancers in Rheumatoid Arthritis (RA) Fibroblast-like Synoviocytes
  • Abstract Number: 2263
    Differentiated Phenotypes at Diagnosis of Sarcoidosis According to the Scadding Classification: Analysis in 1230 Patients
  • Abstract Number: 407
    Digital Disruptive Technology for Rehabilitation Following Elective Surgery for Low Back Pain, Knee and Hip Osteoarthritis: A Systematic Review and Meta-Analysis
  • Abstract Number: 2837
    Diminished STAT-3 Phosphorylation and Associated Cell Pathways Characterize MMF-Treated Systemic Lupus Erythematosus Patients
  • Abstract Number: 126
    Direct Interaction between Autoreactive B Cells and Endothelial Colony Forming Cells Induces Cytokine Production from B Cells through B Cell Receptor and IL-6-JAK2-STAT3 Signaling Pathway, Suppressing Proliferation of Endothelial Colony Forming Cells in Systemic Sclerosis
  • Abstract Number: 2185
    Direct Medical Costs for Medicare Patients with Rheumatoid Arthritis
  • Abstract Number: 229
    Disability Status, Mortality, and Leading Causes of Death in Seropositive Rheumatoid Arthritis Patients: A Population-Based Study in Korea
  • Abstract Number: 2953
    Disappearance of Autoantibodies in RA: Does It Occur with Current Treatment Strategies? a Long-Term Follow-up Study in Patients That Achieved DMARD-Free Sustained Remission
  • Abstract Number: 698
    Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
  • Abstract Number: 1881
    Discovery and Validation of Novel Disease Subsets in 806 Patients with Takayasu’s Arteritis across Four International Cohorts
  • Abstract Number: 37
    Discovery of DWP213388, a Potent ITK and BTK Dual Target Inhibitor with Excellent Efficacy, As a Treatment for Autoimmune Diseases
  • Abstract Number: 2706
    Discriminant Validity and Reliability of World Scleroderma Foundation (WSF) Definition of Skin Ulcers in Systemic Sclerosis
  • Abstract Number: 447
    Discriminating between Central & Peripheral Pain Sensitization Using a Slowly Repeated Evoked Pain Protocol
  • Abstract Number: 2860
    Disease Activity and Its Measurement in Patients with RA across the U.S.: Data from the Rheumatology Informatics System for Effectiveness (RISE) Registry
  • Abstract Number: 1840
    Disease Activity in Rheumatoid Arthritis Patients Is Influenced By Countries’ Socioeconomics: Results from the Meteor Registry
  • Abstract Number: 2501
    Disease Activity Is the Major Discriminator When Defining Refractory Rheumatoid Arthritis
  • Abstract Number: 614
    Disease Activity One Year after Addition of Bucillamine or Sulfasaladine to Methotrexate in Japanese Patients with Rheumatoid Arthritis : Propensity Score Analysis
  • Abstract Number: 2633
    Disease Activity, Organ Damage and Patient-Reported Outcome Measures in Swedish Patients with Recent-Onset SLE
  • Abstract Number: 1602
    Disease Characteristics, Quality of Life, and Work Productivity By Enthesitis Sites: Real-World Data from the US Corrona Psoriatic Arthritis/Spondyloarthritis (PsA/SpA) Registry
  • Abstract Number: 1670
    Disease Course Patterns in Systemic Lupus Erythematosus: Impact on Long-Term Outcomes
  • Abstract Number: 1741
    Disease Duration and Autoantibodies Predict Distinct Skin Score Trajectories in Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 652
    Disease Interception in Psoriasis Patients with Subclinical Joint Inflammation By Interleukin 17 Inhibition with Secukinumab – Data from a Prospective Open Label Study
  • Abstract Number: 543
    Disease Severity Among Bio-Naive RA Patients on Csdmards
  • Abstract Number: 1742
    Disease-Specific Autoantibodies Associate with Remarkably Different Risk of Development of Significant Lung Fibrosis in Systemic Sclerosis
  • Abstract Number: 2646
    Disparities in Antimalarial Prescribing for Systemic Lupus Erythematous Nephritis Using a Real-World, Electronic Health Record
  • Abstract Number: 265
    Disparities in Utilization and Direct Costs of Hospitalizations and Emergency Room Visits in SLE: The Georgia Lupus Registry
  • Abstract Number: 221
    Distal Interphalangeal Joint Involvement and Its Association with Disease Activity in Rheumatoid Arthritis (RA): Analysis Based on a Nationwide RA Database in Japan
  • Abstract Number: 1046
    Distinct Balance of TNF-α/IL-10 in Circulating and Infiltrating CD163+ Macrophages between Rapidly and Slowly Progressive Symptomatic Knee Osteoarthritis
  • Abstract Number: 1014
    Distinct Macrophage Phenotype and Bioenergetic Profiles in Rheumatoid Arthritis
  • Abstract Number: 1074
    Distinct Metabolic Profile in the Urine of Rheumatoid Arthritis Patients:a Possible Link to Arthritis Phenotypes
  • Abstract Number: 1113
    Distinct Pathways in Anti-RNP-Associated Pulmonary Hypertension and Anti-RNP-Associated Raynaud’s Phenomenon
  • Abstract Number: 138
    Distinct Roles of Tfh2, SLAMF7+ Tfh1 Cells and Th1 Cells in the Pathogenesis of IgG4-RD
  • Abstract Number: 207
    Divergent Patterns of Cardiovascular Risk in Biomarkers of Lipids and Subclinical Myocardial Injury during Increased Inflammation in Rheumatoid Arthritis
  • Abstract Number: 1520
    DMARD Hepatotoxicity in Rheumatoid Arthritis and Its Association with the Surrogates of Metabolic Syndrome
  • Abstract Number: 622
    DMARD Withdrawal in RA Patients Achieving Therapeutic Response with Certolizumab Pegol Combined with Dmards: Results from a Canadian Randomized Study
  • Abstract Number: 829
    DNA Damage and Repair in Patients with Cryoglobulinemic Vasculitis Treated with Direct Anti-HCV Drugs
  • Abstract Number: 74
    DNA Methylation of the Dual Specificity Protein Phosphatase 22 (DUSP22) Gene Promoter in Plasma of Patients with Seropositive and Seronegative RA
  • Abstract Number: 2478
    Do Age and Education Influence the Disease Activity Score? an Explorative Analysis in the Norwegian Register of Dmards
  • Abstract Number: 1463
    Do Anti-Citrullinated Protein Antibodies and Anti-Sjögren’s-Syndrome-Related Antigen a Double Positive Patients with Secondary Sjögren’s Syndrome and RA Have Higher Joint Disease Activity?
  • Abstract Number: 1947
    Do Changes in Pain Sensitization and Depressive Symptoms Mediate the Effect of Extreme Weight Loss on Knee Pain Improvement?
  • Abstract Number: 2409
    Do Children with Juvenile Idiopathic Arthritis Play an Active Role in Their Treatment Adherence? First Results of the Rumaji Study
  • Abstract Number: 646
    Do Ethnicity, Degree of Family Relationship, and the Spondyloarthritis Subtype in Affected Relatives Influence the Association between a Positive Family History for Spondyloarthritis and HLA-B27 Carriership? Results from the Worldwide ASAS Cohort
  • Abstract Number: 313
    Do Musculoskeletal Ultrasound and Magnetic Resonance Imaging Identify Synovitis and Tenosynovitis at the Same Joints and Tendons? – a Comparative Study in Patients Presenting with Early Arthritis and Clinically Suspect Arthralgia
  • Abstract Number: 2856
    Do Patients with Moderate or High Disease Activity Escalate RA Therapy According to Treat-to-Target Principles? Results from the Acr’s RISE Registry
  • Abstract Number: 2990
    Do Polymyalgia Rheumatica Patients Have an Increased Risk of Cardiovascular Events?: A Matched-Control Study
  • Abstract Number: 2859
    Do Preventive Cardiology Consults Versus Usual Care Improve Cardiovascular Risk Factor Assessment and Management in Patients with Rheumatoid Arthritis?
  • Abstract Number: 1927
    Do Remission and Low Disease Activity State Go Hand in Hand with Patient’s Perception of Disease Burden and Quality of Life in Systemic Lupus Erythematosus?
  • Abstract Number: 1630
    Do Symptoms of Depression and Anxiety Influence Treatment Response and Long-Term Physical Health Outcomes in Ankylosing Spondylitis?
  • Abstract Number: 2108
    Dock8-Positive CD4 T Cell As Autoantibody-Inducing CD4 T (aiCD4 T) Cell That Causes Systemic Lupus Erythematosus (SLE): Proof of Concept of Self-Organized Criticality Theory As a Cause of SLE
  • Abstract Number: 339
    Documenting Bone Health for Veterans with Rheumatoid Arthritis in an Outpatient Academic Clinic
  • Abstract Number: 337
    Does a Best Practice Alert Improve RA Patient Referral to Preventative Cardiology?
  • Abstract Number: 2200
    Does an 18f-FDG-PET/CT in Patients with Giant Cell Arteritis in Clinical Remission Make Sense?
  • Abstract Number: 544
    Does Anti-Citrullinated Protein Antibody Status Modify Treatment Effect of Certain Biologic DMARDs?
  • Abstract Number: 826
    Does Anti-Glomerular Basement (anti-GBM) Antibody Positivity Correlate with Relapse in Patients with Anti-GBM Disease?
  • Abstract Number: 296
    Does Care By a Multidisciplinary Team Improve Outcomes in Rheumatoid Arthritis? a Randomized Controlled Study
  • Abstract Number: 771
    Does Cognitive Function Change over-Time in Systemic Lupus Erythematosus?
  • Abstract Number: 2842
    Does Leflunomide Have a Role in Giant Cell Arteritis?
  • Abstract Number: 437
    Does Reduction in Mechanical Knee Joint Loading Explain the Beneficial Effects of Weight Loss in Overweight or Obese Patients with Knee Osteoarthritis?
  • Abstract Number: 1944
    Does Renin Angiotensin System Blockade in Addition to Immunosuppressive Therapy Improve Proteinuria in Acute Lupus Nephritis?
  • Abstract Number: 1326
    Does Testing for SAA Is More Beneficial Than CRP for the Follow-up of Patients with Familial Mediterranean Fever ?
  • Abstract Number: 2999
    Does the Incremental Cost of ACPA-Positive Rheumatoid Arthritis Patients Vary By the Care Pathway They Follow?
  • Abstract Number: 2821
    Dose Tapering and Discontinuation of Biological Therapy in Rheumatoid Arthritis Patients in Routine Care – 2-Year Outcomes and Predictors
  • Abstract Number: 418
    Dose-Response Relationship between Neuromuscular Electrical Stimulation and Muscle Function in Patients with Rheumatoid Arthritis
  • Abstract Number: 1899
    Down-Regulation of RNA Processing Protein CFIm25 Amplifies Skin Fibrosis By up-Regulating Pro-Fibrotic Transcripts/Proteins in Systemic Sclerosis
  • Abstract Number: 1112
    Downregulated Expression of Interferon Regulatory Factor 8 in Circulating Monocytes Exhibits Pro-Fibrotic Phenotype in Patients with Systemic Sclerosis
  • Abstract Number: 1058
    Doxycycline Directly Scavenges Reactive Oxygen Species and Inhibits the Formation of Malondialdehyde-Acetaldehyde-Protein Adducts – a Novel Mechanism of Action for an Old Drug
  • Abstract Number: 1259
    Driving Performance and Safety in Rheumatoid Arthritis: A Systematic Review
  • Abstract Number: 2605
    Drug Retention and Response Rates of TNFi Treatment in 13,170 Patients with Psoriatic Arthritis Treated in Routine Care – Pooled Data from the Eurospa Research Network Collaboration
  • Abstract Number: 1867
    Drug Retention and Response Rates of TNFi Treatment in 21,470 Patients with Axial Spondyloarthritis Treated in Clinical Practice– Pooled Data from the Eurospa Research Network Collaboration
  • Abstract Number: 2618
    Drug Survival of Non TNF Inhibitors Bdmards in Psoriatic Arthritis (Ustekinumab/Secukinumab) : A Real-Word Multicentric Cohort of 161 Patients
  • Abstract Number: 552
    Drug Tolerability and Discontinuation Reasons of 7 Biologics in 4466 Treatment Courses of Rheumatoid Arthritis -the Answer Cohort Study-
  • Abstract Number: L17
    Dual Neutralization of IL-17A and IL-17F with Bimekizumab in Patients with Active Psa: Results from a 48-Week Phase 2b, Randomized, Double‑Blind, Placebo-Controlled, Dose-Ranging Study
  • Abstract Number: 1275
    Dual-Energy CT for the Diagnosis of Gout: A Prospective Study in Patients with No Prior History of Gout
  • Abstract Number: 2942
    Dyadic Study of Partner Social Support for Physical Activity and Its Role in the Initiation and Maintenance of Increased Physical Activity Among Insufficiently Active People with Hip/Knee Osteoarthritis
  • Abstract Number: 2002
    Dynamic Compression of Articular Cartilage Explants Increases Formation and Decreases Degradation of Type II Collagen
  • Abstract Number: 304
    Dynamic MRI in Rheumatoid Arthritis for the Assessment of Synovitis Promoting Cartilage Loss
  • Abstract Number: 2777
    Dynamics in Peripheral Blood Cell Counts in Giant Cell Arteritis before Treatment, during Treatment and in Treatment-Free Remission
  • Abstract Number: 1974
    Dynamics of Transcriptional Signatures from Synovial Macrophage Subsets during Acute and Chronic Murine Models of Inflammatory Arthritis
  • Abstract Number: 2079
    Dysbiosis of Gut Microbiomes in Ankylosing Spondylitis
  • Abstract Number: 2067
    Dysbiosis-Dependent Inflammasomes Activation Drives Innate Immune Responses in Ankylosing Spondylitis Patients
  • Abstract Number: 1084
    Dysfunction of the DNASE1L3 Pathway and Antigen Accumulation in Lupus Nephritis
  • Abstract Number: 1330
    Dyskeratotic Cells in Persistent Pruritic Skin Lesions Are Apoptotic and Associated with High Levels of Serum IL-18, and Possibly Predict the Outcomes in Adult-Onset Still’s Disease
  • Abstract Number: 2081
    Dysregulated MiR-125a Promotes Joint Angiogenesis in Psoriatic Arthritis through Altered Bioenergetics
  • Abstract Number: 2031
    Dysregulated NK Cell PLC
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences